Highlights Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:45:17 2025-06-24 pm EDT			5-day change	1st Jan Change
197.37 ^USD	+0.52%		+0.78%	-14.06%

07:53am	Barclays Adjusts Danaher Price Target to $225 From $215	MT
Jun. 09	Some of the biggest splits in Corporate America	RE

Highlights

Some of the biggest splits in Corporate America	Jun. 09	RE
Some of the biggest splits in Corporate America	Jun. 09	RE
AstraZeneca, Danaher to Develop New Precision Medicine Diagnostic Tools	May. 30	MT
Danaher partners with AstraZeneca to develop AI diagnostics	May. 30	AN
Danaher, AstraZeneca Collaborate on Precision Medicine	May. 29	MT
Danaher Corporation Announces the Launch of Partnership with AstraZeneca to Develop and Commercialize Novel Diagnostic Tools and Tests Intended to Help Clinicians Better Determine Which Patients Would Most Benefit from Precision Medicine Treatments	May. 29	CI
Third Point LLC Dissolves Share Stake In Meta, Thermo Fisher Scientific & Cuts Share Stake In Microsoft	May. 15	RE
Danaher Keeps Quarterly Dividend at $0.32 per Share, Payable July 25 to Holders of Record June 27	May. 06	MT
Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025	May. 06	CI
Third Point Investors says fund down in first quarter amid tariffs	May. 02	AN
Veralto posts upbeat first-quarter results, shares up	Apr. 29	RE
Danaher Unit Signs Joint Marketing Deal With Kytopen for Cell Therapy Manufacturing Product	Apr. 29	MT
Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook	Apr. 28	RE
Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook	Apr. 28	RE
Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth	Apr. 22	MT
Danaher beats quarterly profit, expects incremental costs from US tariffs	Apr. 22	RE
Danaher 1Q Results Decline But Top Estimates	Apr. 22	DJ
Danaher Fiscal Q1 Non-GAAP Earnings, Sales Decrease; Fiscal 2025 Adjusted EPS Outlook Issued	Apr. 22	MT
Earnings Flash (DHR) Danaher Posts Fiscal Q1 Sales $5.74B, vs. FactSet Est of $5.57B	Apr. 22	MT
(DHR) DANAHER CORPORATION Sees Fiscal Year 2025 Adjusted EPS Range $7.60 - $7.75	Apr. 22	MT
Earnings Flash (DHR) DANAHER CORPORATION Posts Q1 Adjusted EPS $1.88	Apr. 22	MT
Tranche Update on Danaher Corporation's Equity Buyback Plan announced on July 23, 2024.	Apr. 22	CI
Danaher Corporation Reports Earnings Results for the First Quarter Ended March 28, 2025	Apr. 22	CI
Oxford Nanopore teams up with Danaher subsidiary Cepheid	Apr. 09	AN
PRESS DIGEST- Financial Times - April 2	Apr. 01	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Highlights

Filters